(Updated - June 16, 2025 6:34 AM EDT)

H.C. Wainwright analyst Raghuram Selvaraju upgraded UroGen Pharma (NASDAQ: URGN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE